Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × Alemtuzumab × 90 days × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Clear Cell 1

Interventions

fludarabine 2 Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 Biopsy 2 treosulfan 1 talimogene laherparepvec 1 sodium-iodide symporter 1 sargramostim 1 romidepsin 1 relatlimab 1 pembrolizumab 1 entrectinib 1 cemiplimab 1 brincidofovir 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Polymerase Chain Reaction 1 Photons 1 Mycophenolic Acid 1 Lactones 1 Ipilimumab 1 Immunoglobulin G 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡